Newsvine
  • Welcome
  • Help
  • Report Bug
  • Conversation Tracker
  • Your Column
  • Replies
  • Friends
Type Comments Since You Last CheckedArticle Source Last Checked Stop Tracking All Clear Tracking All
Advertise | AdChoices
Log In | Register
Close the Login Panel
Existing users log in below. New users please register for a free account.

New Users:

Existing Users:

E-Mail:
Password:
Forgot Password?
Please enter the e-mail address or domain name you registered with:
E-Mail/Domain:
Back to Login
Log Out
  • Top News
  • Local News
  • World
  • U.S.
  • Sports
  • Politics
  • Tech
  • Entertainment
  • Science
  • Business
  • Health
  • Odd News
  • More
    • Arts
    • Education
    • Environment
    • Fashion
    • History
    • Home & Garden
    • Not News
    • Religion
    • Travel
Visit GOZO-unlimited's column >>

GOZO-UNLIMITED

I Love You, I Love Myself
Articles Posted: 376  Links Seeded: 8269
Member Since: 6/2008  Last Seen: 2/24/2012

What is Newsvine?

Updated continuously by citizens like you, Newsvine is an instant reflection of what the world is talking about at any given moment.

Get a Free Account
Help
Fun Stuff
  • Your Clippings
  • Leaderboard
  • E-Mail Alerts
  • Top of the Vine
  • Newsvine Live
  • Newsvine Archives
  • The Greenhouse
  • Recommended Articles
  • Wall of Vineness
Put a Seed Newsvine link on your own site

VA Avandia Study Supported Cover Up of Deaths

Seeded on Sat Feb 20, 2010 4:40 PM EST
Read ArticleArticle Source: Medpage Today
health, cover-up, avandia
Seeded by GOZO-unlimited
Advertise | AdChoices

The VA Diabetes Trial analysis that showed no extra cardiovascular risk from rosiglitazone (Avandia) should not be taken as conclusive, cautioned independent investigators and statisticians.

"None of those analyses was randomized," said Daniel Seigel, Sc.D., a retired statistician formerly with the National Institutes of Health who served on the trial's data and safety monitoring committee "They were all akin to observational analyses."

"At none of our meetings did [study investigators] make strong claims that these were definitive analyses," he said.

  • Enjoy this article? Help vote it up the 'Vine.

Published to:

  • GOZO-unlimited's Column, All of Newsvine
  • Groups: none
  • Regions: none
  • Public Discussion (2)
GOZO-unlimited

Another fake study intended to keep the public dumbed down and dead.

  • 1 vote
Reply#1 - Sat Feb 20, 2010 4:42 PM EST
GOZO-unlimited

Here's another one for you: The Government is so implicated in this.

ADA: VA Diabetes Trial Appears to Vindicate Rosiglitazone (Avandia) Safety:

The last of three major studies of tight glucose control in type 2 diabetes reported at the American Diabetes Association meeting here contained a stunning surprise as a bonus -- an apparent cardiovascular exoneration of rosiglitazone (Avandia).

Like ADVANCE and ACCORD, the other trials, the nearly 1,800-patient Veterans Affairs Diabetes Trial (VADT) found no significant reduction in cardiovascular deaths or events over 7.5 years in patients treated aggressively for glycemic control compared with standard therapy, reported William C. Duckworth, M.D., of the University of Arizona.

http://www.medpagetoday.com/MeetingCoverage/ADA/9749

  • 1 vote
#1.1 - Sat Feb 20, 2010 4:45 PM EST
Reply
Leave a Comment:
You're in Easy Mode. If you prefer, you can use XHTML Mode instead.
You're in XHTML Mode. If you prefer, you can use Easy Mode instead.
(XHTML tags allowed - a,b,blockquote,br,code,dd,dl,dt,del,em,h2,h3,h4,i,ins,li,ol,p,pre,q,strong,ul)
Newsvine Privacy Statement
As a new user, you may notice a few temporary content restrictions. Click here for more info.
FUN STUFF:
  • Leaderboard |
  • E-Mail Alerts |
  • Top of the Vine |
  • Newsvine Live |
  • Newsvine Archives |
  • The Greenhouse |
COMPANY STUFF:
  • Code of Honor |
  • Company Info |
  • Contact Us |
  • Jobs |
  • User Agreement |
  • Privacy Policy |
  • About our ads
LEGAL STUFF:
  • © 2005-2012 Newsvine, Inc. |
  • Newsvine® is a registered trademark of Newsvine, Inc. |
  • Newsvine is a property of msnbc.com